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Objective: Trials testing promising interventions in knee osteoarthritis (OA) often fail to show pain reductions. This
may be due to change in activity whereby a person's pain decreases, leading them to increase their activity levels,
in turn increasing pain back to baseline levels. Using data from a trial of a beneficial treatment for knee pain, we
explored whether activity changes might mask a treatment's effect on pain, by looking at whether activity levels
increased with effective treatment and whether change in activity level related to change in pain.
Design: During the InRespond trial (ISRCTN55059760) participants wore an accelerometer for 7 days before and
during treatments. We assessed change in pain on treatment using scores for overall knee pain and pain in a
nominated pain-aggravating activity both in the last week and evaluated change in different types of activity
using accelerometer data. Principal components analysis tested whether change in activity and pain outcomes
were correlated and created composites combining them. We then tested whether activity, pain or the composites
showed a treatment effect, and examined their responsiveness.
Results: In the 61 participants (mean age 64.5 years, 38% women, mean overall knee pain score 5.08 (0–10)),
activity levels mostly decreased during the trial. Principal component analyses suggested that pain and activity
did not correlate highly, loading on different components. Treatment that showed significant effects on pain did
not show similar effects on either activity (e.g. the active treatment had a slightly greater reduction in total steps
taken than the control treatment (difference 1942.6 steps/week, p ¼ 0.42) nor on composites combining activity
and pain. Pain outcomes were the most responsive; static loading (standing) outcomes were the most responsive
activity outcome.
Conclusion: We found no evidence to support the hypothesis that activity levels increase during effective OA
treatment and might account for the negligible pain effects of OA treatments.1. Introduction
In osteoarthritis (OA), interventions that have shown promise often
fail to produce positive treatment effects in randomised trials [1]. There
are numerous possible explanations for this occurrence, including the
lack of treatment efficacy and targeting the wrong subtype of OA. One
additional explanation is that the trial design may not be optimal to
detect treatment efficacy. Pain, a core outcome for OA trials [2,3], and
featured in 95% of OA trials [4], may be influenced by complex factorss Manchester (ROAM), Centre for
alth Science Centre, The Univers
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including activities of participants. Activity has been found to both
exacerbate and reduce pain in OA; on the one hand increased injurious
joint loading may lead exacerbation of pain [5], whereas therapeutic
exercise may reduce pain [6].
In-keeping with the ‘fear/avoidance’model of pain [7], patients with
OA likely maintain their activity level at an acceptable/tolerable pain
level so as to avoid exacerbating pain. There is evidence that pain is a
primary reason for avoiding or limiting physical activity [8,9]. When an
intervention reduces pain, patients may increase their activity levels, andEpidemiology Versus Arthritis, Centre for Musculoskeletal Research, Institute for
ity of Manchester, Manchester, M13 9PT, United Kingdom.
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sesses only pain and not activity may miss this change in activity and
pain, showing only an absence of pain reduction. Recent work using
observational data has shown that combining information on pain and
walking together can produce increased sensitivity to change over time
[10], and stronger associations with radiographic OA [11], making this a
promising approach to detect treatment effects in interventional clinical
trials.
We sought to investigate the possibility that increased physical ac-
tivity which may increase pain, occurs in patients on effective treatment
and that this may mask the treatment effect. We note that this inquiry is
necessarily limited to treatments shown to be efficacious. We examined
this question in the context of the InRespond trial, a trial demonstrating
that, in selected patients, a lateral wedge insole reduced pain in those
with knee OA [12].
We hypothesized that with an effective treatment that reduced pain,
physical activity may increase and that this, in turn, may exacerbate knee
pain, yielding a blunted pain response to effective treatments. To test this
hypothesis, we used data from the InRespond trial to firstly test whether
there was change in activity during a period when the participant was
randomised to effective treatment. We suspected that pain reduction
might not affect all types of activity equally, so we explored whether
specific types of activity changed. Next, we characterised the relationship
between pain and activity – testing our assumption that pain and activity
were related. Assuming that this was the case, we then attempted to
create a single multidimensional composite outcome that combined ac-
tivity and pain which would be more sensitive to change than the pain
outcome alone and could be an outcome in future treatment studies.
2. Methods
This is a secondary analysis using data from the InRespond trial
(ISRCTN55059760), a randomised controlled cross-over trial of 5 lateral
wedge insoles with medial arch support versus neutral insoles in persons
with painful medial knee OA [12]. In the trial, persons with painful knee
OA were screened by examination to exclude those with patellofemoral
tenderness and in a gait laboratory to exclude persons who did not show
reductions in their knee adductionmoments when using the wedge insole
were randomized to either wedge or neutral insole. The study design was
a 24-week AB crossover trial, with 8 weeks’ intervention and an 8-week
washout between treatments. Each participant therefore had four visits:
the baseline pre-randomisation visit, the 8-week visit at the end of the
first treatment period, a 16-week visit at the end of the washout and a
24-week visit at the end of the second treatment period.
2.1. Participants
Inclusion and exclusion criteria for trial participants have been pub-
lished [12], but were generally: age 40–85 years; knee pain in the past
week of 4 out of 10 on an 11-point scale, and Kellgren/Lawrence (K/L)
[13] grade of 2–4 in the painful knee (as scored by a musculoskeletal
radiologist) on a posteroanterior or anteroposterior radiograph obtained
within the last 2 years that showed definite medial (but no definite
lateral) narrowing. Patellofemoral OA had to be less severe than medial
OA and could not have a K/L grade of 3. Additionally subjects must
have had medial joint line tenderness upon examination by an experi-
enced physical therapist (MJC), a stable medication regimen for 3
months, and a willingness to wear insoles in shoes for 4 h daily. The
knee with the more severe pain was selected as the study knee, although
each participant was provided with bilateral insoles and instructed to
wear them in both shoes. In the rare case where pain was rated equally in
both knees, the dominant knee was selected for the study.
2.2. Activity monitoring
Activity data collection was performed using the ActivPAL2
accelerometer (PAL Technologies Ltd., Glasgow, UK); a small thigh-
mounted 3-axis accelerometer (sampling rate: 20 Hz) to collect data
on acceleration, orientation, and time worn, using proprietary algo-
rithms to derive step count, and classify device orientation. Activity
monitors were posted to participants approximately 10 days prior to
the baseline, 8 week, and 24 week visits, meaning that activity data
were contemporaneous with the timeframe of the pain questions
asked at the clinic visit. Participants were asked to wear the activity
monitors constantly throughout the 7-day monitoring period until the
visit, when the device was returned, and data downloaded. The de-
vice attached to the thigh directly with water resistant tape (Tega-
derm™, 3 M Medical, Bracknell, UK). No instructions on target
activity levels were provided, and participants were expected to
continue their typical daily activity levels throughout the trial. We did
not obtain 16 week accelerometer data to limit respondent burden
and because we assumed an absence of carryover effects to the
baseline on the second treatment period, corroborated in our analysis
of the pain outcomes [12].
For each of the three ActivPAL observations, the first 7 complete
days' worth of activity data were used in the analysis, giving a fixed,
comparable time period across all visits and patients. ActivPAL soft-
ware (ActivPAL 3 software, version 7.2.32) calculated step count and
the amount of time monitored. Additionally, the samples collected were
categorised according to the devices’ orientation into one of three
categories: oriented upright and moving (during which we assumed the
participant to be walking/active); upright, but not moving (in which
we assumed the participant was standing/weight bearing on their
knees); and oriented horizontally (during which we assumed the
participant was sedentary - sitting/lying/not weight bearing on their
knees).
The output from the ActivPAL software outlined above allowed the
calculation of the following nine derived activity outcomes deemed a
priori to be meaningful for patients with knee OA: total steps taken; total
time spent sedentary; total time spent standing; total time spent walking;
total upright time (the sum of the time spent standing and walking); and
estimated total energy expenditure (calculated automatically by the
software). Using the participants' baseline height to approximate stride
length (where stride length ¼ baseline height  0.415 for males, and
baseline height  0.413 for females [14]), we calculated the average
walking speed to be total steps taken  estimate stride lengthtotal time walking . We also calculated the
total number of ‘fast’ steps taken. Fast steps were defined in two ways: 1)
steps taken at a rate of 100/min (hereon: ‘rapid steps’), and 2) Steps
taken at a speed of 1.2 m/s (hereon: ‘brisk steps’). This latter definition
required the step speed, and was therefore deemed potentially more
accurate, but with an additional assumption about stride length. Both
definitions were based on data from a previous study, consistent with
more intense, higher-loading walking patterns thought to indicate
intense loading/weight bearing, and which we assumed would exacer-
bate more pain than slower walking [15,16].2.3. Pain outcomes
InRespond featured three pain outcomes: the KOOS pain subscale,
and two 0–10 numerical rating scales (NRS) for pain intensity; one
assessing knee pain in the last week, and one for pain in a nominated
pain-aggravating activity. For this latter outcome, participants were
asked to rate average pain in the last week during the one action
deemed to consistently cause the most knee pain (for example, walking
downstairs). This activity was selected by the participant at the baseline
visit, and fixed throughout the study. For both NRS's, a rating of
0 indicated no pain at all, and 10 indicated the worst pain imaginable.
All three pain outcomes were assessed at the baseline, 8 week, 16 week,
and 24 week visits. The 16-week observation was excluded from this
analysis, as contemporaneous activity data was not available at this visit
(see above).
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The analysis for this study was carried out in three stages.
The initial stage examined the relationship between pain and activity
outcomes in which we constructed composites using principal compo-
nents analysis (PCA) using a method previously described [17]. The
components created in the PCA would be the composite outcomes. We
expected to see one of two possible solutions from the principal com-
ponents analysis: a one-component model (assuming that pain and ac-
tivity are highly correlated, and therefore collapsed into one factor), or a
two-component model (assuming that pain and activity are moderately
correlated, splitting into two factors). Additionally, we examined scree
plots of the PCAmodel to test which definition was most appropriate. If it
was apparent from the scree plot that neither the one- nor theTable 1
Baseline characteristics of study sample.
Outcome Statistic Neutral insole first (AB) group
(N ¼ up to 31)
# of
observations
Observed data only Observed &
(N ¼ 31 in
Females frequency
(%)
31 10 (32.26) –
Age at screening
visit
mean (SD) 31 64.65 (9.35) –
BMI at screening
visit
mean (SD) 30 28.24 (3.47) –
Total time
ActivPAL
monitor worn
for (days)
median
(IQR)
31 6.97 (6.89–7.00) 6.97 (6.89–
Total Steps taken median
(IQR)
31 52548.00
(34378.00–65728.00)
52548.00
(34378.00–
Time spent
sedentary
(lying/sitting)
(hrs)
median
(IQR)
31 124.37
(119.55–132.69)
124.37 (11
Time spent
standing (hrs)
median
(IQR)
31 29.20 (18.76–33.84) 29.20 (18.7
Time spent
walking (hrs)
median
(IQR)
31 11.60 (7.64–13.77) 11.60 (7.64
Upright time
(hrs)
median
(IQR)
31 39.38 (29.85–45.84) 39.38 (29.8
Total energy
expenditure
(MetH)
median
(IQR)
31 232.86
(225.15–239.35)
232.86 (22
Walking speed
(km/h)
median
(IQR)
31 3.18 (3.00–3.51) 3.18 (3.00–
Total number of
‘rapid’ steps
takena
median
(IQR)
31 13103.00
(7777.00–21821.00)
13103.00
(7777.00–2
Total number of
‘brisk’ steps
taken**
median
(IQR)
31 10049.00
(5795.00–16441.00)
10049.00
(5795.00–1
Pain in last week mean (SD) 31 4.94 (1.95) 4.94 (1.95)
Pain in
nominated
activity
mean (SD) 31 6.03 (1.83) 6.03 (1.83)
KOOS pain
subscale scorey
mean (SD) 31 54.93 (16.91) 54.93 (16.9
KOOS symptom
subscale scorey
mean (SD) 31 56.68 (19.47) –
KOOS ADL
subscale scorey
mean (SD) 31 63.66 (18.10) –
KOOS sports and
recreation
subscale scorey
mean (SD) 28 47.14 (27.77) –
KOOS QoL
subscale scorey
mean (SD) 31 40.12 (19.15) –
Variables denoted with a dash () were not included in the imputation model.
‘Observed & Imputed’ column presents descriptive statistics estimated from the impu
a ‛Rapid step’ defined as a step taken at a rate  100 steps/min; **'brisk step’ define
100 to 0 - Increases represent improvement; decreases represent worsening; ADL ¼ A
3
two-component models were appropriate, and that a solution with more
than two components was a better fit for the data, we extracted the
appropriate number of components. All solutions would be compared in
the subsequent analyses. We used orthogonal rotation before examining
component loadings to enhance interpretability (except in the
one-component solution, as it makes no difference to the loading
coefficients).
In the second analysis stage, we took the selected outcomes and
composites generated from the PCA, and assessed whether activity and/
or pain changed after 8 weeks’ intervention. To assess change in activity,
we used random-effects panel linear regression. We analysed the data
using a regression model featuring the change from baseline to post-
treatment visit (at weeks 8 and 24) of the outcome of interest as the
outcome, with treatment type (coded where 0 ¼ neutral insole, andLateral wedge first (BA) group
(N ¼ up to 30)
Imputed
all cases)
# of
observations
Observed data only Observed & Imputed
(N ¼ 30 in all cases)
30 13 (43.33) –
30 64.37 (8.33) –
30 28.33 (3.42) –
7.00) 27 6.98 (6.87–7.00) 6.98 (6.82–7.00)
65728.00)
27 48064.00
(32084.00–59730.00)
48684.80
(39800.60–59609.40)
9.55–132.69) 27 127.09
(112.99–134.88)
126.76 (114.79–133.91)
6–33.84) 27 28.19 (21.27–36.49) 28.89 (21.57–35.95)
–13.77) 27 11.07 (7.27–12.88) 10.96 (7.80–12.88)
5–45.84) 27 37.75 (31.45–51.19) 39.30 (31.95–48.69)
5.15–239.35) 27 232.28
(225.83–235.33)
230.93 (225.63–235.55)
3.51) 27 3.21 (3.03–3.33) 3.20 (3.03–3.35)
1821.00)
27 12558.00
(8842.00–16321.00)
12786.60
(8934.20–17599.80)
6441.00)
27 8763.00
(7536.00–11720.00)
8919.80
(7293.10–12051.20)
30 5.23 (1.33) 5.23
(1.33)
30 6.00 (1.58) 6.00 (1.58)
1) 30 55.56 (12.51) 55.56 (12.51)
28 57.91 (16.10) –
29 62.12 (13.40) –
24 43.96 (19.56) –
30 40.21 (16.22) –
tation datasets. Medians were estimated with simultaneous quantile regression.
d as a step taken at a speed  1.2 m/s; yKOOS subscales are reverse-scored from
ctivities of Daily Living; QoL ¼ Quality of Life.
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the outcome as a covariate. This model therefore assessed change after 8
weeks of intervention for the pain outcomes, the activity outcomes and
the composites, using two post-treatment observations per participant
(one for each of the two interventions, neutral and lateral wedge insole),
and one baseline (pre-randomisation) observation. The panel model
accounted for within-person correlation, as there were multiple obser-
vations per participant.
A total of 18 regression models were run, one for each of the 12
outcomes of interest (3 pain outcomes, and 9 activity outcomes), and a
further 6 for the 6 composite components extracted from the PCA (cor-
responding to the 3-, 2-, and 1-component solutions extracted). We also
included the total ActivPAL wear time at baseline and follow-up as
covariates, to control for the different lengths of use (which was
approximately, but not exactly 7 days for every patient [Table 1]). We did
not control for ActivPAL wear time in the models that only considered
pain, as wear time was irrelevant to these models.
In the third stage of analysis, to assess responsiveness of all outcomes,
the pain, activity and composite outcomes were all converted to z-scores,
allowing for direct comparisons of the magnitude of change between
outcomes with different units and variances. All outcomes and compos-
ites were collapsed into one ‘z-score’ variable, with a categorical variable
to indicate the outcome type (coded from 0 to 17, representing the 18
considered outcomes – 3 pain outcomes, 9 activity outcomes, and 6
composites). We formally tested for differences in magnitude of
responsiveness in a random-effects panel linear regression model, with
change in the ‘z-score’ variable at follow-up as the outcome, and treat-
ment type (coded 0 ¼ neutral insole, and 1 ¼ lateral wedge insole),
outcome type (the categorical variable coded 0–17), and a treatment
type-by-outcome type interaction effect as predictor variables, and ‘z-
score’ at baseline, total ActivPAL wear time at baseline, and follow-up as
covariates.
In all analyses, we used multiple imputation by chained equations
(MICE) assuming missing data were missing-at-random. The multiple
imputation model used data from all three visits of interest (baseline, 8
weeks, and 24 weeks) and predictive mean matching (PMM) to best
emulate the distributions of the observed variables. The PCA was per-
formed individually on each of the 10 imputed datasets, and the
extracted components re-combined to produce one estimate per
component using Rubin's rules [19,20] after performing the
change-over-time analysis.
Baseline characteristics were described using means and standard
deviations for normally distributed continuous variables, medians and
interquartile ranges for skewed continuous variables, and frequencies
and percentages for categorical variables. 95% confidence intervals were
constructed around all estimates to assess precision, and statistical sig-
nificance. All analyses were conducted using Stata (version 14.0) [21].
3. Results
Baseline characteristics of InRespond participants are shown in
Table 1. Activity levels varied widely, with total step counts ranging from
2940 steps per day to 21,567 steps per day. In total, 308 (15.30%) of the
2013 possible observations were imputed: 3.58% of baseline observa-
tions, 15.65% of post-treatment 1 observations, and 26.68% of post-
treatment 2 observations. The imputed and observed datasets showed
similar results, with slightly decreased activity levels in the imputed
datasets (Table 1).
Stage 1. Association between Activity & Pain (Principal Components
Analysis).
Scree plots from the principal components analysis of all pain and
activity outcomes (see Supplementary Fig. 1) suggested a three-
component solution, and therefore this was extracted alongside the
planned one- and two-component solutions.
Variable loadings on the one component solution were essentially4
split, with all activity variables loading highly, and pain outcomes
loading almost not at all (see Table 2). For example, total step taken was
highly correlated (0.95) with this component but pain in the last week
was weakly correlated with it (0.07). We called this component the ‘ac-
tivity’ composite.
The two-component solution however, produced two components
that featured limited overlap between pain and activity (see Table 2). The
walking-related activity variables loaded strongly on the first component,
and the three pain outcomes loaded moderately onto the second
component, as well as sedentary time, standing time, and upright time
(the sum of standing and walking time). We called these two components
the ‘walking’ and ‘loading/pain’ composites, respectively.
Finally, the three-component solution produced, like the one-
component solution, little overlap between pain and activity. The first
component (‘alt_walking’) loaded almost exclusively with the walking-
related activity outcomes. The variables that correlated best with this
component were total number of rapid or brisk steps taken
(correlation¼ 0.96) whereas pain on nominated activity was the variable
with the weakest correlation (0.02). The second (‘static loading’) loaded
with sedentary time, standing time, and upright time, suggesting that this
type of non-walking activity time was discrete from walking, but also
discrete from pain. The third component (‘pain’) loaded strongly with the
3 pain outcomes only, and had only negligible loading from the activity
outcomes.
Stage 2. Differences in Pain and Activity between Footwear Conditions.
With respect to pain outcomes, change in pain during nominated
activity differed between the two insole conditions, favouring the lateral
wedge insole (b ¼ 0.72 pts; 95% CI -1.30 to 0.15; p ¼ 0.01). The
lateral wedge insoles also produced a change in pain in the last week
(0.79 pts 95% CI -1.32 to 0.26; p < 0.01), although the between-
conditions test was only of borderline significance (b ¼ 0.51; 95% CI
-1.20 to 0.18, p ¼ 0.15; Table 3).
Activity levels decreased under both treatment conditions. Only
walking speed remained unchanged (Table 3). Correspondingly, total
sedentary time increased significantly. Both the number of rapid steps
and total standing time were significantly reduced on lateral wedges and
not on neutral insoles, but the difference between the two treatments did
not reach significance (see Table 3). In general, there were no note-
worthy differences between insoles in activity parameters, although
confidence intervals around estimates were wide.
3.1. Differences in composite outcomes between Footwear Conditions
We then assessed whether the composite outcome scores differed
between neutral and lateral wedge insoles (see Table 3). The ‘activity’,
‘walking’, and ‘alt-walking’ composites decreased in both the lateral and
neutral insole conditions during treatment, and no difference was found
between the interventions. The ‘loading/pain’ composite did not differ
either within or between conditions. The ‘static loading’ composite
(comprised mostly of sedentary/standing variables) was significantly
lower after 8 weeks of lateral wedge use, but not after.
Differences between insole conditions in all composite outcomes did
not meet the threshold for statistical significance.
Stage 3. Responsiveness of All Outcomes – Pain, Activity, and
Composites.
With respect to responsiveness, only the pain in nominated activity
produced a significant difference between insole treatments, suggesting
that this outcome was the most sensitive to change following interven-
tion (see Table 4). This outcome was both the most sensitive pain
outcome and the most sensitive outcome overall. The next-most
responsive pain outcome was the ‘pain in the last week’ outcome, with
the KOOS pain subscale being the least responsive.
Of the activity outcomes, time spent standing was the most sensitive
outcome to change on treatment. Upright time, which was the sum of
Table 2
Combining Pain and Activity Measures at baseline from 61 participants in the InRespond Trial: Results of Factor Analyses for 1, 2 and 3 component solutionsc.
Outcome 1-component
solution
2-component solution 3-component solution
Component 1 -
“Activity”
Component 1 -
“Walking”
Component 2 -
“Loading/Pain”
Component 1 -
“walking”
Component 2 - “Static
Loading”
Component 3 -
“Pain”
Total steps taken 0.95 (0.93–0.94) 0.96 (0.93–0.95) 0.12 (0.15–0.21) 0.94 (0.90–0.93) 0.28 (0.27–0.32) 0.04 (0.03–0.10)
Time spent sedentary (lying/
sitting) (hrs)
0.62 (0.65 to
0.62)
0.43 (0.39 to
0.32)
0.74 (0.81 to
0.76)
0.23 (0.22 to
0.18)
0.88 (0.89 to0.87) 0.15 (0.12–0.15)
Time spent standing (hrs) 0.50 (0.49–0.53) 0.29 (0.16–0.26) 0.76 (0.76–0.83) 0.04 (0.01 to
0.02)
0.96 (0.93–0.95) 0.07 (0.11 to
0.06)
Time spent walking (hrs) 0.94 (0.85–0.89) 0.92 (0.81–0.86) 0.22 (0.25–0.32) 0.86 (0.71–0.79) 0.39 (0.41–0.49) 0.03 (0.06–0.16)
Upright time (hrs) 0.72 (0.71–0.74) 0.54 (0.40–0.50) 0.71 (0.74–0.82) 0.31 (0.24–0.27) 0.94 (0.95–0.96) 0.05 (0.04 to
0.02)
Total energy expenditure
(MetH)
0.80 (0.77–0.79) 0.81 (0.75–0.79) 0.10 (0.14–0.21) 0.73 (0.65–0.70) 0.34 (0.34–0.39) 0.16 (0.15–0.20)
Walking speed (km/h) 0.42 (0.35–0.39) 0.53 (0.47–0.54) 0.29 (0.30 to
0.20)
0.71 (0.65–0.70) 0.39 (0.41 to0.32) 0.06 (0.20 to
0.08)
Total number of ‘rapid’ steps
takena
0.91 (0.81–0.88) 0.95 (0.87–0.93) 0.01 (0.03–0.07) 0.96 (0.92–0.96) 0.14 (0.08–0.14) 0.05 (0.00–0.05)
Total number of ‘brisk’ steps
takenb
0.86 (0.80–0.84) 0.92 (0.87–0.90) 0.05 (0.01 to 0.01) 0.96 (0.92–0.95) 0.04 (0.01–0.08) 0.03 (0.01 to
0.05)
Pain in last week 0.07 (0.04–0.11) 0.28 (0.27–0.36) 0.68 (0.62 to
0.55)
0.10 (0.05–0.11) 0.09 (0.09 to0.04) 0.91 (0.89–0.91)
Pain in nominated activity 0.01 (0.00–0.07) 0.21 (0.23–0.31) 0.66 (0.61 to
0.52)
0.02 (0.02–0.05) 0.07 (0.09 to0.03) 0.91 (0.87–0.90)
KOOS pain subscale scorec 0.01 (0.01 to
0.04)
0.20 (0.26 to
0.20)
0.63 (0.52–0.60) 0.03 (0.05 to
0.01)
0.09 (0.07–0.13) 0.84 (0.83 to
0.77)
Components have been given summary names by the authors to help interpretation.
Coefficient displayed is the correlation in observed dataset (minimum/maximum inmultiple imputation datasets), The higher this coefficient, the greater the correlation
with the underlying component. For example, in the 3-component solution, pain outcomes ‘load’ on the 3rd factor with all pain variables showing high correlation with
the component. The negative sign for loading for KOOS is because less pain translates into higher KOOS pain scores.
a ‛Rapid step’ defined as a step taken at a rate 100 steps/min.
b ‛Brisk step’ defined as a step taken at a speed 1.2 m/s.
c KOOS pain subscale is reverse-scored - Increases represent improvement; decreases represent worsening.
M.J. Parkes et al. Osteoarthritis and Cartilage Open xxx (xxxx) xxxstanding and walking time, had marginally less responsiveness (standing
time standardised change ¼ 0.23; 95% CI -0.53 to 0.07; p ¼ 0.13 versus
upright time standardised change ¼ 0.22; 95% CI -0.52 to 0.07;
p ¼ 0.14), suggesting that walking time added little to improveTable 3
Change in Pain and Activity after 8 Weeks' use of Intervention.
Outcome Neutral insole
least squares mean (95% CI), p***
Individual outcomes
Total steps taken 8412.55 (12731.49 to 4093.60),
<0.01
Time spent sedentary (lying/sitting) (hrs) 3.87 (0.72–7.02), 0.02
Time spent standing (hrs) 0.85 (3.60 to 1.90), 0.55
Time spent walking (hrs) 1.82 (2.71 to 0.94), <0.01
Upright time (hrs) 2.67 (5.78 to 0.44), 0.09
Total energy expenditure (MetH) 1.96 (3.78 to 0.14), 0.04
Walking speed (km/h) 0.02 (0.14 to 0.09), 0.71
Total number of ‘rapid’ steps takena 2092.76 (4272.99 to 87.47), 0.06
Total number of ‘brisk’ steps takenb 1463.11 (3260.23 to 334.01), 0.11
Pain in last week‡ (0–10) 0.28 (0.79 to 0.22), 0.27
Pain in nominated activity‡ (0–10) 0.24 (0.77 to 0.29), 0.38
KOOS pain subscale scorec‡ (100–0) 4.75 (1.03–8.47), 0.01
Composite Outcomes
1-component model: ‘Activity’ component 0.33 (0.54 to 0.12), <0.01
2-component model: ‘Walking’ component 0.35 (0.55 to 0.15), <0.01
2-component model: ‘Loading/Pain’
component
0.02 (0.27 to 0.23), 0.87
3-component model: ‘Alt-walking’ component 0.26 (0.47 to 0.04), 0.02
3-component model: ‘Static loading’
component
0.20 (0.46 to 0.06), 0.13
3-component model: ‘Pain’ componenta 0.22 (0.45 to 0.02), 0.07
In all components, except the ‘pain’ component (denoted '***'), increases in the score
***P values relate to a test of whether the coefficients stated differ from zero.
All estimates come from models controlling for ActivPAL wear time, except those de
a ‛Rapid step’ defined as a step taken at a rate  100 steps/min.
b ‛Brisk step’ defined as a step taken at a speed  1.2 m/s.
c KOOS pain subscale is reverse-scred - Increases represent improvement; decrease
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responsiveness. The other activity outcomes had relatively poor
responsiveness overall, with standardised changes ranging from 0.17
(total energy expenditure) to 0.01 (total number of brisk steps).
Improvements in responsiveness using the composite outcomesLateral wedge Difference between interventions
least squares mean (95% CI), p least squares mean (95% CI), p
10355.14 (14560.76 to 6149.52),
<0.01
1942.60 (6716.94 to 2831.75),
0.42
6.84 (3.63–10.06), <0.01 2.97 (1.12 to 7.07), 0.16
3.49 (6.23 to 0.74), 0.01 2.64 (6.40 to 1.12), 0.17
2.16 (3.09 to 1.23), <0.01 0.33 (1.37 to 0.70), 0.52
5.65 (8.77 to 2.52), <0.01 2.97 (7.07 to 1.12), 0.16
3.09 (5.00 to 1.18), <0.01 1.13 (3.05 to 0.79), 0.25
0.00 (0.11 to 0.11), 0.95 0.02 (0.13 to 0.17), 0.81
2394.42 (4472.64 to 316.20), 0.02 301.67 (2679.79 to 2076.46), 0.80
1622.24 (3471.36 to 226.88), 0.09 159.13 (2566.60 to 2248.33), 0.90
0.79 (1.32 to 0.26), <0.01 0.51 (1.20 to 0.18), 0.15
0.96 (1.49 to 0.43), <0.01 0.72 (1.30 to 0.15), 0.01
4.00 (0.40–7.60), 0.03 0.75 (4.94 to 3.45), 0.73
0.48 (0.69 to 0.27), <0.01 0.15 (0.38 to 0.09), 0.22
0.48 (0.67 to 0.28), <0.01 0.13 (0.34 to 0.09), 0.24
0.10 (0.35 to 0.15), 0.43 0.08 (0.42 to 0.26), 0.64
0.26 (0.46 to 0.06), 0.01 0.00 (0.26 to 0.26), 0.98
0.45 (0.71 to 0.20), <0.01 0.25 (0.60 to 0.10), 0.15
0.43 (0.66 to 0.20), <0.01 0.22 (0.49 to 0.05), 0.11
represent beneficial effects; decreases represent negative effects.
noted with a z.
s represent worsening.
Table 4
Comparative Responsiveness of Pain and Activity Outcomesc.
Outcome Difference between interventions
(expressed in standard deviations)
least squares mean (95% CI), p
Individual outcomes
Total steps taken 0.07 (0.37 to 0.23), 0.65
Time spent sedentary (lying/sitting) (hrs) 0.16 (0.14 to 0.45), 0.29
Time spent standing (hrs) 0.23 (0.53 to 0.07), 0.13
Time spent walking (hrs) 0.07 (0.38 to 0.24), 0.65
Upright time (hrs) 0.22 (0.52 to 0.07), 0.14
Total energy expenditure (MetH) 0.17 (0.47 to 0.13), 0.26
Walking speed (km/h) 0.07 (0.34 to 0.48), 0.72
Total number of ‘rapid’ steps takena 0.02 (0.33 to 0.29), 0.91
Total number of ‘brisk’ steps takenb 0.01 (0.35 to 0.33), 0.95
Pain in last week‡ 0.25 (0.58 to 0.08), 0.14
Pain in nominated activity‡ 0.33 (0.62 to 0.04), 0.02
KOOS pain subscale scorec‡ 0.04 (0.34 to 0.26), 0.81
Composite Outcomes
1-component model: ‘Activity’ component 0.13 (0.42 to 0.16), 0.38
2-component model: ‘Walking’ component 0.13 (0.43 to 0.16), 0.37
2-component model: ‘Loading/Pain’ component 0.02 (0.32 to 0.28), 0.88
3-component model: ‘Alt-walking’ component 0.00 (0.32 to 0.31), 0.99
3-component model: ‘Static loading’ component 0.24 (0.55 to 0.08), 0.14
3-component model: ‘Pain’ component***‡ 0.24 (0.53 to 0.06), 0.12
In all components, except the ‘pain’ component (denoted '***'), increases in the
score represent beneficial effects; decreases represent negative effects.
All estimates come frommodels controlling for ActivPAL wear time, except those
denoted with a z.
Numbers shown are z scores. The larger the z score, the greater the change with
the treatment.
a ‛Rapid step’ defined as a step taken at a rate 100 steps/min.
b ‛Brisk step’ defined as a step taken at a speed 1.2 m/s.
c KOOS pain subscale is reverse-scored - Increases represent improvement;
decreases represent worsening.
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nent model, and the ‘activity’ composite from the 1-component model
had greater responsiveness than any of their constituent walking and
loading-related outcomes. Only the pain composite from the 3-compo-
nent model produced a difference between insoles that approached sta-
tistical significance.
4. Discussion
The hypothesis for this study was that, with an effective pain-
reducing treatment, physical activity may increase, in turn exacer-
bating knee pain, therefore making an efficacious treatment look less
beneficial when the analysis focused on pain alone. However, we found
little evidence that activity changed nor that this affected the measure-
ment of pain. We examined a variety of different measures of activity
assessed using an accelerometer before and during treatment and found
little evidence that any of them changed during treatment.
We found only a weak association between pain and activity out-
comes. There was some limited overlap between static knee loading
variables (standing/sedentary time) and pain, but only in one of the three
PCA models tested. In a person with knee pain, standing may be an
avoidable behaviour, whereas walking may be more difficult for patients
to avoid without disruption to daily activities.
The pain treatment effect size reported in this study is smaller than
that in the main trial report [12], although, like in the main report, the
outcome previously found to be most sensitive to change, pain on
nominated activity [22], showed the largest treatment effect and met
criteria for statistical significance. The diminished effect sizes are
perhaps due to this analysis making use of the pre-randomisation design
(which used 3 observations per participant – baseline, and 2
post-treatment observations), rather than the one used in the trial pub-
lication [18] which used 4 observations per participant – 2 pre- and two
post-treatment observations, and correspondingly a different imputation6
model. This latter analysis was not possible, as activity level was not
recorded at week 16 in the trial (the post-washout observation). We
excluded the post-washout pain observations in order to use only the
follow-ups where activity was collected, allowing a fair direct compari-
son between pain and activity.
Our study addressed a different question than previous studies. Using
data from the OAI, Lo et al. [10] reported that the correlation of WOMAC
pain score adjusted for physical activity level with Kellgren and Lawrence
grade was better than its correlation with WOMAC pain score alone,
suggesting an association of activity with severity of radiographic OA.
Allen and colleagues [11] showed in knee OA patients that activity
adjusted pain correlated better with functional limitation than did pain
alone. Both these studies were cross sectional and did not address the
effect of treatment on pain or the combination of pain and physical
activity.
There are several limitations to our study. This was an exploratory
study, and was not designed initially to address the pain/activity hy-
pothesis examined in this paper: As already mentioned, the InRespond
trial did not collect activity post-washout, and with the large variances in
the activity outcome seen in this trial (Table 1) that may be important to
the analysis. The absence of data at this time point may have led us to fail
to show significant findings because of the enhanced variance induced by
imputation. The treatment effect in InRespond was small and it is
possible that activity levels would be more likely to fluctuate with a more
effective treatment.
In this study, we have assumed a relatively simple relationship be-
tween pain and activity that ignores psychological factors, such as the
influence of coping strategies or depressive symptoms, which might
obfuscate the relationship between pain and activity.
Our definitions of brisk and rapid walking were informed by expert
advice from researchers in the OA community familiar with activity
patterns typical of patients with OA. However, the mean walking speed
(approximately 3 km/h) was relatively close to the definition of a brisk
step (1.2 m/s¼ 4.32 km/h) Further work examining the choice of cut-off
value for brisk and rapid steps may be appropriate to establish how this
impacts sensitivity to change in activity. We used two definitions of rapid
walking – one that used data directly from the accelerometer only, and
one that made an additional assumption about average stride length
based on participant height. Both definitions had similar effect sizes, and
correlation between the two definitions was high (Baseline Pearson's
correlation ¼ 0.92; 95% CI 0.81 to 1.03; p < 0.001; post-treatment
Pearson's correlation ¼ 0.92; 95% CI 0.76 to 1.07; p < 0.001), indi-
cating very little difference between the two definitions.
We found no effect of treatment on our composite outcomes, but our
analysis may not have been sufficiently powered to detect such effects.
Due to the nature of the device used and outcomes chosen to describe
activity, it was not possible to discern precise information about partic-
ular types of activity undertaken by study participants, and how these
may have changed during the study. For example, we were not able to
distinguish stair use or participation in exercise. Collecting more self-
report data on change in activity levels (for example asking partici-
pants about participation in exercise), or making use of a more complex
device that captures more of this type of information objectively (for
example using a GPS-linked smartwatch/smartphone) would allow
further insight into these possible manifestations of activity change.
5. Conclusion
This study found modest changes in pain but little change in activity
following treatment with lateral wedge insoles in those with painful
medial knee OA. Activity did not increase with pain reduction. The
creation of composite outcomes combining data on pain and activity
outcomes identified intriguing interrelations between static loading-type
outcomes (standing time and sedentary time) and pain, and not walking-
type variables, but these composites did not improve the ability to detect
treatment effects.
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